November 25 | 2021
2cureX offentliggör delårsrapport för det tredje kvartalet och första nio månader 2021
Read more
October 29 | 2021
2cureX – Banbrytande cancerbehandlingstest rullas ut – Mangold Insight Analys
Read more
October 15 | 2021
2cureX successfully completed the EU-project MicroCaT and received the final financial tranche of a 3,0 MEUR grant.
Read more
October 12 | 2021
2cureX provides commercial goals for 2022 at Live Strategy Update on the 12th of October 2021.
Read more
October 5 | 2021
2cureX signs distribution agreement with Labormed in Slovenia
Read more
September 28 | 2021
Specialized diagnostic solutions leader Werfen, to distribute 2cureX products in Spain
Read more
August 26 | 2021
2cureX offentliggör delårsrapport för det andra kvartalet och första halvåret 2021
Read more
August 26 | 2021
2cureX publishes interim report for the second quarter and first half of 2021
Read more
June 22 | 2021
2cureX appoints 2 new VPs for its Commercial Operations
Read more
June 1 | 2021
Management exercise all warrants within the framework of the 2018 incentive program
Read more
May 27 | 2021
2cureX publishes interim report for the first quarter of 2021
Read more
May 27 | 2021
2cureX offentliggör delårsrapport för det första kvartalet 2021
Read more
May 27 | 2021
Kommuniké från årsstämma i 2cureX AB
Read more
May 27 | 2021
Communiqué from the Annual General Meeting of 2cureX AB
Read more
May 11 | 2021
Warrants of series TO1 were subscribed to approximately 96.75 percent and 2cureX AB receives approximately SEK 31.40 million.
Read more
May 11 | 2021
Teckningsoptioner av serie TO1 tecknades till cirka 96,75 procent och 2cureX AB tillförs cirka 31,40 MSEK
Read more
May 6 | 2021
2cureX offentliggör årsredovisning för räkenskapsåret 2020
Read more
May 6 | 2021
2cureX publishes the annual report for the fiscal year 2020
Read more